Hepagene 雅创医药

Hepagene.com

雅创医药

ABOUT HEPAGENE

Non-alcoholic Steatohepatitis (NASH)

Chronic Hepatitis B Infection (HBV)

PIPELINE

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH

About HPG1860

About NASH

About Hepagene Therapeutics, Inc

MANAGEMENT TEAM

MANAGEMENT TEAM
Our team has advanced knowledge and deep industry experience in drug discovery, preclinical development, and clinical research. Innovative medicines are being developed
according to global standard with the ultimate mission to benefit the patient community. With rapid growth of the company and great career development potential, we welcome professionals across different disciplines to join the venture.